| Company type | Non-profit |
|---|---|
| Founded | 1994 in Cambridge, MA |
| Founder | William W. Li, MD and Vincent W. Li, MD (co-founders) |
| Headquarters | Cambridge, MA, U.S. |
| Revenue | 1,772,286 United States dollar (2017)  |
| Total assets | 359,298 United States dollar (2022) |
| Website | angio.org |
The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply. [1] In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer. [2] In 2010, the president and co-founder of the Angiogenesis Foundation, William Li, gave a well-received presentation at the TED conference on cancer prevention through antiangiogenic nutrition. [3]
Co-founder Dr. William Li won the 2024 Dr. Andrew von Eschenbach Award for his work in angiogenesis. [4]
